Barbara Caulfield, Michael Malacek, Peter Root, Stephen Holmes, Doug Campos-Outcalt, Roger Klein, Kenneth Offit, Stephen Pauker, David Veenstra, Katrina Armstrong, Kathryn Phillips | GenomeWeb
Barbara Caulfield has resigned her role as executive VP and general counsel at Affymetrix and will leave the company on June 13 to take a position with a private law firm, according to a US Securities and Exchange Commission document. She will continue to serve as secretary to the company’s board of directors.
 
Caulfield is taking members of her legal team from Affymetrix with her to the Dewey LeBoeuf law firm. 
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.